Ventilator Associated Bacterial Pneumonia (VABP) caused by Acinetobacter Baumannii-calcoaceticus Complex

DBCOND0159091Infections Organisms

Ventilator Associated Bacterial Pneumonia (VABP) caused by Acinetobacter Baumannii-calcoaceticus Complex is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Infections
Organisms
Procedural and Postoperative Injuries
Product issues
Respiratory Tract Diseases
Indicated drugs: Durlobactam
Sulbactam

What you can answer from here — as of October 24, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Ventilator Associated Bacterial Pneumonia (VABP) caused by Acinetobacter Baumannii-calcoaceticus Complex share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account